Ohad Hammer Overview
- Firm
- Pontifax Venture...
- Primary Position
-
Partner & Board...
- Primary Industry
-
Healthcare
- Active Board Seats
-
8
- Med. Deal Size
-
- Med. Valuation
-
Ohad Hammer General Information
Biography
Mr. Ohad Hammer serves as Board Member at Adcytherix. He also serves as a Partner at Pontifax Venture Capital. He served as Board Member at Pi Therapeutics. He serves as Board Member at Adcendo and Precirix. He served as a Member of the Supervisory Board at Emergence Therapeutics. He is a Board Member of Keros Therapeutics and AgomAb Therapeutics. He joined Pontifax in 2009 and is involved in identifying as well as evaluating new investment opportunities. He focuses on early-stage projects and oversees scouting, due diligence and company formation. He also supports development and business development activities within our early-stage portfolio companies. He obtained his M.S. in Biology from Tel-Aviv University. He was a Board Member at TargEDys. He serves as Board of director at Explore Bio. He serves as Board Member at Step Pharma.
Contact Information
Address
- 14 Shenkar Street
- Herzliya 46725
- Israel
Ohad Hammer Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Pontifax Venture Capital | Investor | Partner & Board Member | Herzliya, Israel | Venture Capital |
Ohad Hammer Board Seats (8)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Adcendo | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Frederiksberg, Denmark | |
Adcytherix | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Marseille, France | |
AgomAb | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Antwerp, Belgium | |
Keros Therapeutics | Biotechnology | Publicly Held | Formerly VC-backed | Lexington, MA | |
Pontifax Venture Capital | Herzliya, Israel |
Ohad Hammer Lead Partner on Deals (20)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Adcendo | 04-Apr-2023 | Later Stage VC (Series A) | Completed | Drug Discovery | Frederiksberg, Denmark | |
AgomAb | 13-Jul-2022 | Completed | Drug Discovery | Antwerp, Belgium | ||
Precirix | 16-Mar-2022 | Completed | Biotechnology | Brussels, Belgium | ||
Emergence Therapeutics | 07-Dec-2021 | Completed | Drug Discovery | Duisburg, Germany | ||
PulseSight Therapeutics | 04-Aug-2021 | Completed | Drug Discovery | Paris, France | ||
Step Pharma | 24-Mar-2021 | Completed | Drug Discovery | Saint-Genis-Pouilly, France | ||
Keros Therapeutics | 04-Mar-2020 | Completed | Biotechnology | Lexington, MA | ||
Metabomed | 19-Dec-2019 | Completed | Drug Discovery | Yavne, Israel | ||
AgomAb | 10-Oct-2019 | Early Stage VC (Series A) | Completed | Drug Discovery | Antwerp, Belgium | |
Pi Therapeutics | 29-May-2019 | Early Stage VC (Series B) | Completed | Drug Discovery | Ness Ziona, Israel |
Ohad Hammer Network (220)
Board Members (117)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Francesco Sinigaglia Ph.D | PulseSight Therapeutics | PulseSight Therapeutics | Paris, France | |
Ximing Ding Ph.D | Adcytherix | Pureos Bioventures | Marseille, France | |
Precirix | Precirix | Brussels, Belgium | ||
Dynacure | Self | France | ||
Step Pharma | Inserm Transfert | Saint-Genis-Pouilly, France |
Portfolio Executives (97)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Carmel Lynch Ph.D | Adcendo | Chief Development Officer | 04-Apr-2023 | Frederiksberg, Denmark |
Henrik Stage | Adcendo | Co-Founder | 04-Apr-2023 | Frederiksberg, Denmark |
Adcendo | Chief Technology Officer | 04-Apr-2023 | Frederiksberg, Denmark | |
Adcendo | VP Operations, General Manager & Co-founder | 04-Apr-2023 | Frederiksberg, Denmark | |
Adcendo | ESG & Finance Director | 04-Apr-2023 | Frederiksberg, Denmark |
Fund Team Members (6)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Silvia Noiman Ph.D | Pontifax Venture Capital | Pontifax Fund IV | Herzliya, Israel |
Silvia Noiman Ph.D | Pontifax Venture Capital | Pontifax Fund III | Herzliya, Israel |
Pontifax Venture Capital | Herzliya, Israel | ||
Pontifax Venture Capital | Herzliya, Israel | ||
Pontifax Venture Capital | Herzliya, Israel |
Ohad Hammer Affiliated Funds (3)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Pontifax Fund III | Pontifax Venture Capital | Venture - General | Closed | 2011 | ||||
Pontifax Fund IV | Pontifax Venture Capital | Venture - General | Closed | 2015 | ||||
Pontifax Fund VI | Pontifax Venture Capital | Venture - General | Closed | 2020 |
Ohad Hammer FAQs
-
Who is Ohad Hammer?
Mr. Ohad Hammer serves as Board Member at Adcytherix.
-
How much does Ohad Hammer typically invest?
Ohad Hammer's median deal size is
. -
What is Ohad Hammer’s main position?
Ohad Hammer’s primary position is Partner & Board Member.
-
How many active board seats does Ohad Hammer hold?
Ohad Hammer holds 8 board seats including Adcendo, Adcytherix, AgomAb, Keros Therapeutics, and Pontifax Venture Capital.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »